A Phase 3 Clinical Study of QLM3004 in Delaying Myopia in Children

NCT06151587 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

735

Enrollment

INDUSTRY

Sponsor class

Conditions

Myopia

Interventions

DRUG: QLM3004 Concentration 1
DRUG: QLM3004 Concentration 2
DRUG: QLM3004 Concentration 3
OTHER: Placebo

Sponsor

Qilu Pharmaceutical Co., Ltd.